Affordability brings along with it, life-style changes – a trend that’s driving the increasing incidences of cardiovascular diseases in all major economies of the world. Driven by a positive demographic outlook, increasing awareness and access to quality healthcare, the global cardiovascular devices sector is expected to continue its growth trajectory. This sector remains the largest among all medical equipment sectors, globally.
Cardiovascular Devices ResearchViews is your number one portal for cardiovascular devices market related news, research, analysis and deals data. Sign up for our free weekly research update or download the latest research papers on the cardiovascular devices sector’s hottest topics by clicking on the links below.
|
The US electrophysiology devices market was valued at $901.5 million in 2008. Driven by acceptance and penetration of catheter based ablation procedures to treat atrial fibrillation (AFib), the market is forecast to grow by 10.9% annually during 2008-2015 to reach $1.9 billion by 2015.
In a market which has been witnessing significant consolidation activities, Biosense Webster (a Johnson & Johnson company), St. Jude Medical and Boston Scientific Corporation remain the leading players. However, with multiple companies pursuing an AFib indication for cardiac ablation systems, dynamism in the prevalent competitive landscape can never be ruled out.
|
|
This latest electrophysiology devices market data and analysis was taken from the research report
"US Electrophysiology Devices Market: Strategic Market Analysis and Insight to 2015" published by GlobalData - for more information on this report,
Click Here
|
|
* Indicates Mandatory
|